Arrivo BioVentures Overview

  • Founded
  • 2015

  • Status
  • Private

  • Employees
  • 11

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $49M

  • Investors
  • 5

Arrivo BioVentures General Information


Developer of reformulated biopharmaceutical drugs designed to identify biologics and small molecules to improve patient care. The company's drugs are produced by reformulated product or a new chemical entity, to identify regulatory strategies to expedite the path to approval through efficient clinical programs, enabling biotech companies to meet their drug demands to improve patient's lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Aerial Center Executive Park
  • 9001 Aerial Center Parkway, Suite 110
  • Morrisville, NC 27560-9731
  • United States
+1 (919) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arrivo BioVentures Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 25-May-2016 $49M 0000 Completed Clinical Trials - Phase 2
To view Arrivo BioVentures’s complete valuation and funding history, request access »

Arrivo BioVentures Executive Team (7)

Name Title Board Seat Contact Info
Stephen Butts Co-Founder, Chief Executive Officer & Manager
Karen Adams Chief Financial Officer
Michael Ackermann Ph.D Co-Founder, Manager, Chief Business Officer, Chief Operating Officer & Board Member
Jed Black MD Co-Founder & Scientific Advisor
William Wofford JD Co-Founder, Manager, General Counsel and Head of Corporate Development
You’re viewing 5 of 7 executive team members. Get the full list »

Arrivo BioVentures Board Members (3)

Name Representing Role Since
Bruce Leuchter MD Self Board Member 000 0000
Christopher Dougherty Self Manager & Board Observer 000 0000
David Adair MD Solas BioVentures Board Member 000 0000
To view Arrivo BioVentures’s complete board members history, request access »

Arrivo BioVentures Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arrivo BioVentures Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hockey Stick Investments Family Office Minority 000 0000 000000 0
Jackson Davis Angel (individual) Minority 000 0000 000000 0
Jazz Pharmaceuticals Corporation Minority 000 0000 000000 0
Rex Health Ventures Corporate Venture Capital Minority 000 0000 000000 0
Solas BioVentures Venture Capital Minority 000 0000 000000 0
To view Arrivo BioVentures’s complete investors history, request access »